Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer

Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer

<p>Abstract</p> <p>Background</p> <p>The VEGF family of ligands and receptors are intimately involved in tumor angiogenesis, lymphangiogenesis and metastasis. The evaluation of VEGF ligand/receptor ratios may provide a more profound understanding of the involvement of t...

Full description

Bibliographic Details
Main Authors:	Terracciano Luigi, Baumhoer Daniel, Zlobec Inti, Eppenberger Manuela, Lugli Alessandro
Format:	Article
Language:	English
Published:	BMC 2010-03-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/10/93

Similar Items

TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
by: Inti Zlobec, et al.
Published: (2010-12-01)

The battle for prognosis at the invasive front of colorectal cancer
by: Alessandro Lugli, et al.
Published: (2020-08-01)

Loss of Cdx2 expression in primary tumors and lymph node metastases is specific for mismatch repair-deficiency in colorectal cancer
by: Heather eDawson, et al.
Published: (2013-10-01)

Stratification and prognostic relevance of Jass’s molecular classification of colorectal cancer
by: Inti eZlobec, et al.
Published: (2012-02-01)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
by: Yixi Li, et al.
Published: (2021-10-01)

Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
by: Vanessa L. Hale, et al.
Published: (2018-10-01)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
by: Shou-Sheng Liu, et al.
Published: (2018-07-01)

An assay for screening cells for mismatch repair proficiency in vivo
by: Wu, Shiau-Yin
Published: (2012)

Characterization of <it>CDKN2A</it>(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
by: Bihl Michel P, et al.
Published: (2012-08-01)

MISMATCH REPAIR GENES IN COLORECTAL CARCINOMA
by: Asim Qureshi, et al.
Published: (2015-04-01)

Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer
by: Guoying Zhou, et al.
Published: (2018-07-01)

Orthotopic liver metastasis mouse models of mismatch repair-proficient colorectal cancer recapitulate clinical inefficacy of immune checkpoint blockade
by: Ho, William Wee Teck.
Published: (2021)

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
by: Mark Yarchoan, et al.
Published: (2020-02-01)

Sporadic colorectal polyps and mismatch repair proteins
by: Mahsa Molaei, et al.
Published: (2011-01-01)

Retained PTEN Expression Preferentially Identifies Mismatch Repair-Proficient Breast Cancers
by: Nicola Fusco, et al.
Published: (2016-06-01)

Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
by: Rosa M. Jimenez-Rodriguez, et al.
Published: (2020-01-01)

Classification of colorectal tissue images from high throughput tissue microarrays by ensemble deep learning methods
by: Huu-Giao Nguyen, et al.
Published: (2021-01-01)

Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
by: Annika Blank, et al.
Published: (2019-10-01)

The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.
by: Christopher H Lieu, et al.
Published: (2013-01-01)

Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
by: Annika Blank, et al.
Published: (2018-08-01)

VEGF-A, VEGF-C, and VEGF-D in Colorectal Cancer Progression
by: Mark L. George, et al.
Published: (2001-01-01)

Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
by: Cong-Min Zhang, et al.
Published: (2016-09-01)

DNA mismatch repair gene mutations in human colorectal carcinogenesis
by: Beck, Nicholas Edward
Published: (2001)

The THE FREQUENCY OF MISMATCH REPAIR DEFICIENCY IN COLORECTAL CARCINOMA DETERMINED BY IMMUNOHISTOCHEMISTRY
by: Maria Naseem, et al.
Published: (2021-08-01)

DNA mismatch repair in population-based studies of colorectal cancer
by: Coggins, Ronald Paul
Published: (2005)

Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer
by: Michael A. Mcilhatton, et al.
Published: (2016-01-01)

Role of Intra- and Peritumoral Budding in the Interdisciplinary Management of Rectal Cancer Patients
by: Inti Zlobec, et al.
Published: (2012-01-01)

A digital pathology-based shotgun-proteomics approach to biomarker discovery in colorectal cancer
by: Stefan Zahnd, et al.
Published: (2019-01-01)

Role of <it>APC </it>and DNA mismatch repair genes in the development of colorectal cancers
by: Roy Deodutta, et al.
Published: (2003-12-01)

Cancer risk and biomarker analysis in mismatch repair deficient colorectal carcinoma
by: Barrow, Emma
Published: (2009)

High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
by: Raoul A Droeser, et al.
Published: (2013-01-01)

Prognostic and Predictive Values of Mismatch Repair Deficiency in Non-Metastatic Colorectal Cancer
by: Zhaohui Jin, et al.
Published: (2021-01-01)

Evaluation of Mismatch Repair Gene Polymorphisms and their Contribution to Colorectal Cancer and its Subsets
by: Mrkonjic, Miralem
Published: (2009)

Evaluation of Mismatch Repair Gene Polymorphisms and their Contribution to Colorectal Cancer and its Subsets
by: Mrkonjic, Miralem
Published: (2009)

An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers.
by: Ajay Goel, et al.
Published: (2010-02-01)

HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
by: Luo H, et al.
Published: (2021-04-01)

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
by: Elena Fountzilas, et al.
Published: (2019-04-01)

HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
by: Giuseppe Sconocchia, et al.
Published: (2014-01-01)

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial
by: Linda Mileshkin, et al.
Published: (2021-06-01)

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
by: Guido Giordano, et al.
Published: (2019-01-01)